Cell and gene therapy is an exploding area of new technology and innovation in the pharmaceutical industry. Mapping of the human genome that led to
Background:
Cell therapy and gene therapy is a new technology that is helping patients with previously untreatable diseases. The increase in viable cell and gene therapies necessitated regulatory guidance documents to ensure processes were implemented that assure quality and safety of this new technology. As the landscape changes and new regulations are implemented those who are manufacturing or treating patients with these new technologies should stay up-to-date on recent regulatory changes. This webinar addresses regulatory expectations as well as provides an overview of cell and gene therapy.
Course Objectives:
• Responsible agencies for regulation
• Understanding the drug approval process
• Definition of cell and gene therapy
• Risk assessment
• Implementing processes for safety and quality
• Challenges in
• GMP/GLP/GTP
Why Should You Attend:
Stem cells, as well as transfected/transformed cells, are powering significant breakthroughs in medicine. The FDA has been guarded in response to applications for this type of therapy. Due to the need to provide
Course Outline:
• Overview of cell and gene therapy
• Regulatory agency guidelines
• Determining regulatory status
• Minimal manipulation / homologous use
• Process steps
• Critical quality attributes
• Labeling
• Problems and pitfalls
• Deviation reporting
• FDA inspections and enforcement
What You Get:
• Training Reference Materials
• Live Q&A with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Research and Development Scientists
• Quality Control
• Quality Assurance
• Regulatory Affairs
• Clinicians
• Compliance Professionals
• Academic Researchers
• Production Supervisors
• Medical Affairs
• Process Developers
• Production Engineers
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Get Instant Access 90 Minutes View Program |
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Get Instant Access 60 Minutes View Program |
Packaging and Labeling for Commercial and Clinical Products
Get Instant Access 90 Minutes View Program |
Providing DMFs in eCTD format
Get Instant Access 90 Minutes View Program |
QSR-Compliant Equipment Control & Validation of Processes in the Manufacturing Environment
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry